Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zookeys ; 1185: 181-198, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38074903

RESUMO

In this paper we update the knowledge on the species of Serica McLeay, 1819 (sensu lato) occurring in Yunnan, Sichuan, and Shaanxi provinces, China. Three new species are described: Sericaallonanhua Liu, Ahrens, Li & Su, sp. nov., S.breviantennalis Liu, Ahrens, Li & Su, sp. nov., and S.fengensis Liu, Ahrens, Li & Su, sp. nov. The key to the species groups and species is updated. The habitus and male genitalia of the new species are illustrated, and a map showing their distribution is provided. New distributional data are given for four species.

2.
Front Mol Neurosci ; 16: 1133106, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37033380

RESUMO

The mechanism of brain aging is not fully understood. Few studies have attempted to identify molecular changes using bioinformatics at the subregional level in the aging brain. This study aimed to identify the molecular signatures and key genes involved in aging, depending on the brain region. Differentially expressed genes (DEGs) associated with aging of the cerebral cortex (CX), hippocampus (HC), and cerebellum (CB) were identified based on five datasets from the Gene Expression Omnibus (GEO). The molecular signatures of aging were explored using functional and pathway analyses. Hub genes of each brain region were determined by protein-protein interaction network analysis, and commonly expressed DEGs (co-DEGs) were also found. Gene-microRNAs (miRNAs) and gene-disease interactions were constructed using online databases. The expression levels and regional specificity of the hub genes and co-DEGs were validated using animal experiments. In total, 32, 293, and 141 DEGs were identified in aging CX, HC, and CB, respectively. Enrichment analysis indicated molecular changes related to leukocyte invasion, abnormal neurotransmission, and impaired neurogenesis due to inflammation as the major signatures of the CX, HC, and CB. Itgax is a hub gene of cortical aging. Zfp51 and Zfp62 were identified as hub genes involved in hippocampal aging. Itgax and Cxcl10 were identified as hub genes involved in cerebellar aging. S100a8 was the only co-DEG in all three regions. In addition, a series of molecular changes associated with inflammation was observed in all three brain regions. Several miRNAs interact with hub genes and S100a8. The change in gene levels was further validated in an animal experiment. Only the upregulation of Zfp51 and Zfp62 was restricted to the HC. The molecular signatures of aging exhibit regional differences in the brain and seem to be closely related to neuroinflammation. Itgax, Zfp51, Zfp62, Cxcl10, and S100a8 may be key genes and potential targets for the prevention of brain aging.

3.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 27(2): 539-544, 2019 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-30998167

RESUMO

OBJECTIVE: To explore whether the high risk factors possibly leading to hypercoagulative status and thrombosis exist in Thalassemia patients of Guangxi region through detecting plasma tissne factor-bearing microparticles (TF+MP), procoagulatima activity, coagulation and anticoagulation function, fibrinolytic function, endothelial function and platelet count. METHODS: The TF+MP procoagulation activity was detected by chromogenic saubstract method, the levels of tissue factors (TF), tissue factor pathway inhibitor(TFPI), protein C (PC), protein S (PS), antithrombin Ⅲ(AT-Ⅲ), tissue plasminogen activator (tPA), thrombin-activated fibrinolysis inhibitor (TAFI), soluble E-selectin (sE-sel), intercellular adhesion molecule-1 (ICAM-1) and thrombomodulin (TM) were detected by ELISA in thalassemia group (n=71) and control group (n=20 heathy persons). RESULTS: Compared with control group, the AT-Ⅲ level decreased in ß-thalastemia major group (TM) (P<0.05), the AT-Ⅲ level in TM group independeutly posstiody correlated with plt count (r=0.37, P<0.05); the levels of TF and sICAM in α-thalassenia intermediate group (TA) significantly decteased (P<0.05), the procoagulatim activity of TF+MP in ß-thalassemia intermediate group (TI) increased sngnificantly (P<0.05), moreover positively corretated with AT-Ⅲ level (r=0.77, P<0.05). The TF and sICAM-1 levels in normal liver functim group of Thalassemia patients were lower tham those in control group (P<0.01 and P<0.05, respectively), the TF+MP activity between normal and abnormal liver function was significantly different (P<0.05), while there were no significant difference in other correspoding indexes beween thalassemia group and control group as well as between each thalassemia groups. CONCLUSION: The damage of liver function and reduction of anticoagylation substances exist in patients with ß-thalassenia major in Guangxi region, the procoagulation activity of plasma TF+MP in patients with ß-thalassemia intermedia abnormally increases. All the above-mentioned factors may increase the risk of high coagulation status or thrombosis is thalassemia patients, the decrease of TF and SICAM-1 levels in patients with α-thalassemia intermedia may be factor against thrombosis.


Assuntos
Talassemia , Anticoagulantes , Antitrombina III , China , Humanos , Tromboplastina , Ativador de Plasminogênio Tecidual
4.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 26(5): 1471-1476, 2018 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-30295270

RESUMO

OBJECTIVE: To investigate the changes of E-selectin, thrombin-antithrombin complex(TAT), prothrombin fragment 1+2(F1+2), tissue factor(TF)and tissue factor pathway inhibitor(TFPI)before and one year after splenectomy in thalassemia patients. METHODS: A total of 30 thalassemia patients undergoing electric laparoscopic splenectomy and 30 normal controls(NC) were enrolled in the study.Plasma levels of E-selectin, TAT, F1+2, TF and TFPI were detected by enzyme-linked immuno sorbent assay(ELISA). RESULTS: One year after splenectomy,the plasma concentrations of E-selectin, TAT, F1+2, TF, TFPI were significantly higher than those in both preoperative and NC groups.Levels of E-selectin, TAT, F1+2 before splenectomy were significantly higher than those in NC groups. In addition, there was a positive correlation between plasma TF and TFPI level before and after splenectomy, and the levels of TF and TFPI positively correlated with TAT and F1+2, respectively. CONCLUSION: After splenectomy, the platelet count increases, the activity of endothelial cells is injured, the procoagulant factor increases, the blood is in procoagulant state, the TF/TFPI shows an importent role in the thrombosis of thalassemia patieints after splenectomy and may be used to evaluate the prothrombotic state of this diasease.


Assuntos
Coagulação Sanguínea , Talassemia , Humanos , Lipoproteínas , Tromboplastina
5.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 25(2): 622-626, 2017 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-28446324

RESUMO

Microparticles (MP) are small membrane vesicles released from many different cell types in response to cellular activation or apoptosis, which have the procoagulant effect. Hemolytic anemia(HA) is a type of anemia that have a short life expectancy of red blood cells due to the destruction which exceed the hematopoietic compensatory capacity of bone marrow. Sickle cell anemia(SCD), thalassemia and paroxysmal nocturnal hemoglobinuria(PNH) are all characterized by hypercoagulation and thromboembolism (TE). Research shows that MP can promote the formation of hypercoagulative state which in turn increases the risk of thromboembolism in HA. This review mainly summarized the advance research of MP in HA in the past 5 years. Moreover the relationship between the abnormal MP and hypercoagulation in HA, the impact of the related treatment to the MP, the research of MP in animal model of HA and the application of the MP-proteomics in HA are also disscussed.


Assuntos
Anemia Hemolítica/fisiopatologia , Micropartículas Derivadas de Células/fisiologia , Hemoglobinúria Paroxística/fisiopatologia , Animais , Modelos Animais de Doenças , Eritrócitos , Humanos , Trombofilia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...